van Buul-Offers SC - Search Results

1

A comparison of in vitro bioassays to determine cellular glucocorticoid sensitivity.

Vermeer H, Hendriks-Stegeman BI, Verrijn Stuart AA, van Buul-Offers SC, Jansen M. Vermeer H, et al. Among authors: van buul offers sc. Eur J Endocrinol. 2004 Jan;150(1):41-7. doi: 10.1530/eje.0.1500041. Eur J Endocrinol. 2004. PMID: 14713278

2

Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability.

Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M. Vermeer H, et al. J Clin Endocrinol Metab. 2003 Jan;88(1):277-84. doi: 10.1210/jc.2002-020354. J Clin Endocrinol Metab. 2003. PMID: 12519866

3

An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells.

Vermeer H, Hendriks-Stegeman BI, van Suylekom D, Rijkers GT, van Buul-Offers SC, Jansen M. Vermeer H, et al. Among authors: van buul offers sc. Mol Cell Endocrinol. 2004 Apr 15;218(1-2):49-55. doi: 10.1016/j.mce.2003.12.011. Mol Cell Endocrinol. 2004. PMID: 15130510

4

Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice.

Smink JJ, Koster JG, Hendriks-Stegeman BI, Van Buul-Offers SC. Smink JJ, et al. Endocrinology. 1999 Dec;140(12):5876-82. doi: 10.1210/endo.140.12.7174. Endocrinology. 1999. PMID: 10579353

5

A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum.

Vermeer H, Hendriks-Stegeman BI, van den Brink CE, van der Saag PT, van der Burg B, van Buul-Offers SC, Jansen M. Vermeer H, et al. Among authors: van buul offers sc. Clin Endocrinol (Oxf). 2003 Jul;59(1):49-55. doi: 10.1046/j.1365-2265.2003.01793.x. Clin Endocrinol (Oxf). 2003. PMID: 12807503 Clinical Trial.

6

Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus.

van Buul-Offers SC, de Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS, Van den Brande JL. van Buul-Offers SC, et al. J Endocrinol. 1995 Mar;144(3):491-502. doi: 10.1677/joe.0.1440491. J Endocrinol. 1995. PMID: 7537791

7

Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay.

Van Doorn J, Ringeling AM, Shmueli SS, Kuijpers MC, Hokken-Koelega AC, van Buul-Offers SC, Jansen M. Van Doorn J, et al. Clin Endocrinol (Oxf). 1999 May;50(5):601-9. doi: 10.1046/j.1365-2265.1999.00694.x. Clin Endocrinol (Oxf). 1999. PMID: 10468926

8

IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice.

Smink JJ, Koster JG, Gresnigt MG, Rooman R, Koedam JA, Van Buul-Offers SC. Smink JJ, et al. J Endocrinol. 2002 Oct;175(1):143-53. doi: 10.1677/joe.0.1750143. J Endocrinol. 2002. PMID: 12379498

9

Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components.

Smink JJ, Koedam JA, Koster JG, van Buul-Offers SC. Smink JJ, et al. J Endocrinol. 2002 Aug;174(2):343-52. doi: 10.1677/joe.0.1740343. J Endocrinol. 2002. PMID: 12176674

10

Short-term glucocorticoid treatment of prepubertal mice decreases growth and IGF-I expression in the growth plate.

Smink JJ, Gresnigt MG, Hamers N, Koedam JA, Berger R, Van Buul-Offers SC. Smink JJ, et al. J Endocrinol. 2003 Jun;177(3):381-8. doi: 10.1677/joe.0.1770381. J Endocrinol. 2003. PMID: 12773118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters